There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
63.67 Cr.Face value
2.00Book value
5.26Div. yield
0.000P/E ratio
0.00P/B ratio
0.00Debt/Eq.
-Market Cap
63.67 Cr.Face value
2.00Book value
5.26Div. yield
0.00%P/E ratio
0.00P/B ratio
0.00Debt/Eq.
-
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 31.61% | 26.32% | 5.29% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Vaishali Pharma Limited is primarily engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients. The company is offering range from Formulations Bulk Drugs APIs Veterinary Products Surgical and Neutraceutical Read more 
Markets APIs, formulations, surgical products, Herbal & Nutraceutical Products, and veterinary supplements with a focus on quality and international presence.
Incorporated on April 25, 2008; listed on NSE – Emerge on August 22, 2017, and migrated to NSE Mainboard on January 15, 2020.
Zero subsidiaries as of the latest Annual Report; holds a non-subsidiary equity investment.
